A Prescription for Change: Citizens United’s Implications for Regulation of Off-Label Promotion of Prescription Pharmaceuticals
Kristie Anne LaSalle
affiliation not provided to SSRN
June 1, 2011
Journal of Law & Policy, Vol. 19, p. 867, 2011
This Note examines the complex regulatory structure that controls off-label promotion of prescription pharmaceuticals. Using the recent case of United States v. Caronia as an example of the unconstitutional shortcomings of this regulatory scheme, the Note analogizes the FDA's obstruse regulatory scheme to the corporate campaign contributions limitations struck down in Citizens United v. FEC, and argues that the same logic applied in Citizens United should be applied to the regulation of truthful speech regarding prescription pharmaceuticals.
Number of Pages in PDF File: 46
Keywords: pharmaceuticals, Citizens United v. FEC, United States v. Caronia, first amendmentAccepted Paper Series
Date posted: July 22, 2011
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo1 in 0.328 seconds